Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tremfya (guselkumab)
Marketing
New IL-23 UC drugs 'rapidly gained significant momentum': report
New drugs are rapidly growing into the established UC market as this IL-23 inhibitor class look to make its mark.
Ben Adams
Nov 18, 2024 8:55am
J&J's Tremya, Lilly's Ebglyss score in new patient groups
Oct 25, 2024 11:00am
New J&J Tremfya ad puts inclusive twist on psoriasis marketing
Oct 16, 2024 4:08pm
J&J leans on oncology growth drivers as Stelara sales slow
Oct 15, 2024 11:45am
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
Oct 7, 2024 10:53am
Tremfya enters crowded ulcerative colitis arena with FDA nod
Sep 11, 2024 6:58pm
